COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,237 Articles (22,733 medRxiv, 8,504 bioRxiv)

Most recent first Previous |  Page 2485: Articles 24841-24850  | Next

No Excess Mortality of COVID-19 in Japan until April, 2020
Kurita, J., Sugawara, T., Sugishita, Y., Ohkusa, Y.
10.1101/2020.07.09.20143164 — Posted: 2020-07-11
SARS-CoV-2 RNA extraction using magnetic beads for rapid large-scale testing by RT-qPCR and RT-LAMP
Klein, S., Mueller, T. G., Khalid, D., Sonntag-Buck, V., Heuser, A.-M., Glass, B., Meurer, M., Morales, I., Schillak, A., Freistaedter, A., Ambiel, I., Winter, S. L., Zimmermann, L., Naumoska, T., Bubeck, F., Kirrmaier, D., Ullrich, S., Barreto-Miranda, I., Anders, S., Grimm, D., Schnitzler, P., Knop, M., Kraeusslich, H.-G., Dao Thi, V. L., Boerner, K., Chlanda, P.
10.1101/2020.07.08.20147561 — Posted: 2020-07-11
COVID-19 causing HELLP-like syndrome in pregnancy and role of angiogenic factors for differential diagnosis
Figueras, F., LLurba, E., Martinez-Portilla, R., Mora, J., Crispi, F., Gratacos, E.
10.1101/2020.07.10.20133801 — Posted: 2020-07-11
Clinical and epidemiological characteristics of children with SARS-CoV-2 infection: case series in Sinaloa
Perez Gaxiola, G., Flores Rocha, R., Valadez Vidarte, J. C., Hernandez Alcaraz, M., Herrera Mendoza, G., Del Real Lugo, M. A.
10.1101/2020.07.07.20146332 — Posted: 2020-07-11
COVID-19 severity is predicted by earlier evidence of accelerated aging
Kuo, C.-L., Pilling, L. C., Atkins, J. C., Masoli, J., Delgado, J., Tignanelli, C., Kuchel, G., Melzer, D., Beckman, K. B., Levine, M.
10.1101/2020.07.10.20147777 — Posted: 2020-07-11
Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection
Seow, J., Graham, C., Merrick, B., Acors, S., Steel, K. J. A., Hemmings, O., O'Bryne, A., Kouphou, N., Pickering, S., Galao, R., Betancor, G., Wilson, H. D., Signell, A. W., Winstone, H., Kerridge, C., Temperton, N., Snell, L., Bisnauthsing, K., Moore, A., Green, A., Martinez, L., Stokes, B., Honey, J., Izquierdo-Barras, A., Arbane, G., Patel, A., OConnell, L., O Hara, G., MacMahon, E., Douthwaite, S., Nebbia, G., Batra, R., Martinez-Nunez, R., Edgeworth, J. D., Neil, S. J. D., Malim, M. H., Doores, K.
10.1101/2020.07.09.20148429 — Posted: 2020-07-11 Discussion: Onsite | Offsite
Antibody dynamics to SARS-CoV-2 in Asymptomatic and Mild COVID-19 patients
Lei, Q., Li, Y., Hou, H., Wang, F., Zhang, Y., Lai, D., Jo-Lewis, B. N., Xu, Z., Zhang, B., Chen, H., Ouyang, Z., Xue, J., Lin, X., Zheng, Y., Yao, Z., Wang, X., Yu, C., Jiang, J., Zhang, H., Qi, H., Guo, S., Huang, S., Sun, Z., Tao, S.-c., Fan, X.
10.1101/2020.07.09.20149633 — Posted: 2020-07-11
Characteristics and transmission dynamics of COVID-19 in healthcare workers at a London teaching hospital
Zheng, C., Hafezi, N., Cooper, V., Davidson, H., Habibi, M., Riley, P., Breathnach, A.
10.1101/2020.07.10.20149237 — Posted: 2020-07-11
Lockdown measures in response to COVID-19 in Sub-Saharan Africa: A rapid study of nine countries
Haider, N., Osman, A. Y., Gadzekpo, A., Akpede, G. O., Asogun, D., Ansumana, R., Lessells, R. J., Khan, P., Hamid, M. M. A., Yeboah-Manu, D., Mboera, L., Shayo, E. H., Mmbaga, B., Urassa, M., Musoke, D., Kapata, N., Ferrand, R. A., Chanda-Kapata, P., Stigler, F., Czypionka, T., Kock, R. A., McCoy, D.
10.1101/2020.07.09.20149054 — Posted: 2020-07-11 Discussion: Onsite
What cost decisiveness? A cost benefit analysis of the lockdown to contain COVID-19 in India
Dutta, M., Husain, Z.
10.1101/2020.07.07.20148338 — Posted: 2020-07-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).